Two adult cases of multisystem inflammatory syndrome associated with SARS-CoV-2

Since the emergence of SARS-CoV-2 worldwide, various manifestations and sequelae have been reported, including COVID-19-associated Kawasaki-like multisystem inflammatory syndrome in children. This dysregulated immune sequela often presents with features of hypotension or shock, cardiac dysfunction, arterial or venous thromboembolism, gastrointestinal discomfort, and protean skin manifestations.1 More recently, the Centers for Disease Control and Prevention has acknowledged an increasing incidence of multisystem inflammatory syndrome in adults (MIS-A).